Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Hematology/Oncology Clinics of North America|April 28, 2020
Tagraxofusp for Blastic Plasmacytoid Dendritic Cell NeoplasmDanielle Hammond, Naveen PemmarajuPathology|March 9, 2021
Clonal haematopoiesis of emerging significanceDanielle Hammond, Sanam LoghaviCurrent Hematologic Malignancy Reports|September 9, 2021
Management and Outcomes of Blast Transformed Chronic Myelomonocytic LeukemiaDanielle Hammond, Guillermo Montalban-BravoJournal of Fungi (Basel, Switzerland)|April 28, 2023
Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and ChallengesNancy N Vuong, Danielle Hammond, Dimitrios P KontoyiannisCancer Journal (Sudbury, Mass.)|May 17, 2023
Germline Predisposition to Myelodysplastic SyndromesGeorgina Gener-Ricos, Yoheved S Gerstein, Danielle Hammond, et al.The British Journal of Psychiatry : the Journal of Mental Science|September 28, 2011
Cost utility of behavioural activation delivered by the non-specialistDavid Ekers, Christine Godfrey, Simon Gilbody, et al.Leukemia & Lymphoma|May 21, 2024
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging fieldLuan Phan, Danielle Hammond, Nathaniel R Wilson, et al.Case Reports in Hematology|May 15, 2026
The First Reported Case of VEXAS Syndrome in Lebanon: Efficacy of Azacitidine as a Therapeutic Option-Case ReportRoudy Issa, Bassem Akiki, Sophie Georgin-Lavialle, et al.Clinical Lymphoma, Myeloma & Leukemia|May 22, 2024
Eosinophilia During Lenalidomide Therapy in Myelodysplastic SyndromeKoji Sasaki, Hagop Kantarjian, Guillermo Montalban-Bravo, et al.Blood Advances|May 5, 2022
Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemiaChong Chyn Chua, Danielle Hammond, Andrew Kent, et al.Pageof 5